OpenAlex Citation Counts

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Resistance looms for KRAS G12C inhibitors and rational tackling strategies
Junmin Zhang, Jilei Zhang, Qing Liu, et al.
Pharmacology & Therapeutics (2021) Vol. 229, pp. 108050-108050
Closed Access | Times Cited: 44

Showing 26-50 of 44 citing articles:

KRAS Pathway-based Therapeutic Approaches in Pancreatic Cancer
Abdullah Althaiban, Anita Thyagarajan, Ravi P. Sahu
Mini-Reviews in Medicinal Chemistry (2022) Vol. 23, Iss. 8, pp. 953-961
Closed Access | Times Cited: 3

Evolution of resistance to KRASG12C inhibitor in a non-small cell lung cancer responder
Elaine Lai‐Han Leung, Jiahui Xu, Shijia Wang, et al.
Research Square (Research Square) (2024)
Open Access

Discovery and development of Krazati (adagrasib/MRTX849), a potent, selective, orally bioavailable, covalent KRASG12C(OFF) inhibitor
Adrian L. Gill, M. Marx
Elsevier eBooks (2024), pp. 205-227
Closed Access

LUMAKRAS® (sotorasib)
Nuria Tamayo, Ryan P. Wurz, Brian A. Lanman
Elsevier eBooks (2024), pp. 173-203
Closed Access

Identifying genes associated with resistance to KRAS G12C inhibitors via machine learning methods
Xiandong Lin, Qinglan Ma, Lei Chen, et al.
Biochimica et Biophysica Acta (BBA) - General Subjects (2023) Vol. 1867, Iss. 12, pp. 130484-130484
Closed Access | Times Cited: 1

Integration of signaling pathway and bromodomain and extra-terminal domain inhibition for the treatment of mutant Kirsten rat sarcoma viral oncogene homolog cancer
Gerhard Hamilton, Sandra Stickler, Barbara Rath
Exploration of Targeted Anti-tumor Therapy (2023), pp. 1027-1038
Open Access | Times Cited: 1

Novel Bicyclic Dione Compounds as KRAS Inhibitors for Treating Cancer
Ram W. Sabnis
ACS Medicinal Chemistry Letters (2022) Vol. 13, Iss. 6, pp. 893-894
Open Access | Times Cited: 2

Small-Molecule Inhibitor of the Oncogenic KRAS^G12C Mutant for the Treatment of Currently Incurable Cancer
Robert B. Kargbo
ACS Medicinal Chemistry Letters (2022) Vol. 13, Iss. 5, pp. 767-769
Open Access | Times Cited: 1

Long-Awaited Small-Molecule Drug Candidate for Drugging the Next Undruggable KRAS^G12D Mutant in Cancer Therapy
Robert B. Kargbo
ACS Medicinal Chemistry Letters (2022) Vol. 13, Iss. 5, pp. 773-774
Open Access | Times Cited: 1

Data from Loss of MLL Induces Epigenetic Dysregulation of Rasgrf1 to Attenuate Kras-Driven Lung Tumorigenesis
Ling-Yu Zhu, Jun-Bo Yuan, Li Zhang, et al.
(2023)
Open Access

The PI3K-AKT-mTOR axis persists as a therapeutic dependency in KRAS^G12D-driven non-small cell lung cancer
William J. McDaid, L Wilson, Helen Adderley, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access

Evolution of resistance to KRAS^G12Cinhibitor in a non-small cell lung cancer responder
Jiahui Xu, Shijia Wang, Ziming Wang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access

Review: Applications of Machine Learning in Computer-Aided Drug Discovery — R0/PR1
SM Bargeen Alam Turzo, Eric R. Hantz, Steffen Lindert
(2022)
Open Access

Recommendation: Applications of Machine Learning in Computer-Aided Drug Discovery — R0/PR4
SM Bargeen Alam Turzo, Eric R. Hantz, Steffen Lindert
(2022)
Open Access

Review: Applications of Machine Learning in Computer-Aided Drug Discovery — R0/PR3
SM Bargeen Alam Turzo, Eric R. Hantz, Steffen Lindert
(2022)
Open Access

Review: Applications of Machine Learning in Computer-Aided Drug Discovery — R0/PR2
SM Bargeen Alam Turzo, Eric R. Hantz, Steffen Lindert
(2022)
Open Access

Recommendation: Applications of Machine Learning in Computer-Aided Drug Discovery — R1/PR5
SM Bargeen Alam Turzo, Eric R. Hantz, Steffen Lindert
(2022)
Open Access

Recommendation: Applications of Machine Learning in Computer-Aided Drug Discovery — R2/PR6
SM Bargeen Alam Turzo, Eric R. Hantz, Steffen Lindert
(2022)
Open Access

Previous Page - Page 2

Cookie	Duration	Description
cookielawinfo-checkbox-advertisement	1 year	Set by the GDPR Cookie Consent plugin, this cookie is used to record the user consent for the cookies in the "Advertisement" category .
cookielawinfo-checkbox-analytics	1 year	Set by the GDPR Cookie Consent plugin, this cookie is used to record the user consent for the cookies in the "Analytics" category .
cookielawinfo-checkbox-functional	1 year	The cookie is set by the GDPR Cookie Consent plugin to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	1 year	Set by the GDPR Cookie Consent plugin, this cookie is used to record the user consent for the cookies in the "Necessary" category .
cookielawinfo-checkbox-others	1 year	Set by the GDPR Cookie Consent plugin, this cookie is used to store the user consent for cookies in the category "Others".
cookielawinfo-checkbox-performance	1 year	Set by the GDPR Cookie Consent plugin, this cookie is used to store the user consent for cookies in the category "Performance".
CookieLawInfoConsent	1 year	Records the default button state of the corresponding category & the status of CCPA. It works only in coordination with the primary cookie.
PHPSESSID	session	This cookie is native to PHP applications. The cookie is used to store and identify a users' unique session ID for the purpose of managing user session on the website. The cookie is a session cookies and is deleted when all the browser windows are closed.

Requested Article:

Showing 26-50 of 44 citing articles:

Your Privacy